The table below shows Oruka Therapeutics, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$88.21M
-$57.84M
-$5.01M
-$10.91M
-$18.76M
-$7.72M
Capital expenditure
$209.00K
$189.00K
$0.00
$2.00K
$43.00K
$19.00K
Investing cash flow
-$96.75M
-$330.13M
$0.00
-$2.00K
-$43.00K
-$19.00K
Dividends paid
-
-
-
-
ORKA operating cash flow (10-K history)
Oruka Therapeutics, Inc. reported operating cash flow of -$88.21M for fiscal year 2025. That is down 52.5% from -$57.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.29M (FY 2013) to -$88.21M. Figures come from the company's audited annual reports as filed with the SEC.